insights_auto
Why is ABVX up ၂.၃၅%?
Dive Deeperchevron_right
ABVX:EPA
Abivax SA
၈၂.၈၀ €
arrow_upward
+၂.၃၅%(+၁.၉၀) 1D
အောက် ၆, GMT+၂ ၁၁:၅၈:၁၈ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABVX...
Open
၈၁.၇၅ €
High
၈၂.၈၅ €
Low
၈၁.၅၀ €
Mkt. cap
၇၂၄.၇၅ ဋေ
Avg. vol.
၁.၅၇ သိန်း
Volume
၁.၂၅ သောင်း
52-wk high
၁၃၉.၀၀ €
52-wk low
၆၀.၄၅ €
EPS
-၅.၂၀ €
Shares outstanding
၈.၇၅ ကုဋေ
No. of employees
၉၈
Open
၈၁.၇၅ €
High
၈၂.၈၅ €
Low
၈၁.၅၀ €
Mkt. cap
၇၂၄.၇၅ ဋေ
Avg. vol.
၁.၅၇ သိန်း
Volume
၁.၂၅ သောင်း
52-wk high
၁၃၉.၀၀ €
52-wk low
၆၀.၄၅ €
EPS
-၅.၂၀ €
Shares outstanding
၈.၇၅ ကုဋေ
No. of employees
၉၈
News stories
From web sources and news partners
EQS News
·
ပြီးခဲ့သည့် ၆ မိနစ်
Solidion Technology (NASDAQ: STI) Sees no Basis to Increase Its Offer to Polar Power, Inc. (NASDAQ: POLA) in Response to Board Rejection of All-Cash Asset Acquisition Proposal | Corporate
Simply Wall Street
·
ပြီးခဲ့သည့် ၄၇ မိနစ်
Will Mood And Mind Drinks Change Walmart's (WMT) Narrative
Axios
·
ပြီးခဲ့သည့် ၁ နာရီ
Wall Street is on track for record profits
Yahoo Finance
·
ပြီးခဲ့သည့် ၃၈ မိနစ်
3 S&P 500 Stocks to Consider Right Now
Profile
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated.
The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France. Wikipedia
About Abivax SA
CEOMarc de Garidel | Hartmut J. Ehrlich
Employees၉၈
Founded၂၀၁၃ ဒီ ၄
Headquarters-
Sector-
Websiteabivax.com